tirzepatide and dairy foods to avoid: the complete guide to eating smarter on GLP-1 therapy Semaglutide and tirzepatide are both

Lean muscle loss is a genuine tradeoff Research consistently shows that roughly 25 to 40 percent of the weight lost on GLP-1 medications is lean body mass, not fat

As obesity becomes more common globally, the potential patient pool for GLP-1 receptor agonists expands significantly

Holmes GM, Browning KN, Tong M, et al

Johnson, G

What to Expect When Getting Semaglutide from a Prescriber The initial consultation typically includes a health history review, current weight and metabolic measurements, and discussion of weight loss goals and previous attempts

Cosmos Study December 16, 2025 Dual-Team Study Team A:Kersten Bartelt, RNNicholas Volker Team B:Tony Dunnigan, MDEric Barkley Key Findings Among patients with type 2 diabetes, GLP-1 use was associated with a 32% lower fracture risk for those with either osteopenia or osteoporosis